[HTML][HTML] Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

M Taquet, Z Skorniewska, T De Deyn… - The Lancet …, 2024 - thelancet.com
Background COVID-19 is known to be associated with increased risks of cognitive and
psychiatric outcomes after the acute phase of disease. We aimed to assess whether these …

Post-Intensive Care Syndrome Family

AC Smith, HN Ferguson, RM Russell… - Critical Care …, 2025 - criticalcare.theclinics.com
Each year, over 5 million patients are admitted to the intensive care unit (ICU). 1 During their
ICU hospitalization, their family members often experience symptoms of psychological …

Fatigue and cognitive dysfunction in previously hospitalized patients with COVID-19: A 1-year follow-up

I Andreasson, HC Persson, A Björkdahl - PloS one, 2024 - journals.plos.org
Purpose The aim was to longitudinally explore changes in fatigue-and cognition-related
symptoms during the first year after hospital treatment for COVID-19. Method Patients …

Diagnostic accuracy of the Montreal Cognitive Assessment in screening for cognitive impairment in initially hospitalized COVID-19 patients: Findings from the …

S Klinkhammer, E Verwijk, G Geurtsen… - Journal of the …, 2025 - cambridge.org
Objective: This study aimed to investigate the prevalence and nature of cognitive impairment
among severely ill COVID-19 patients and the effectiveness of the Montreal Cognitive …

Exploring the effects of COVID-19 on verbal memory function in schizophrenia: Multiple case study and brief literature review

B Keřková, M Kolenič, K Knížková, A Hrubý… - Applied …, 2024 - Taylor & Francis
Individuals recovering from COVID-19 may experience persistent impairment in verbal
memory performance, potentially due to illness-related hippocampal injury. Although verbal …

Infection, neuroinflammation and interventions for healthy brain and longevity

T Fülöp, C Ramassamy, G Lacombe, EH Frost… - Brain and Mental Health …, 2024 - Springer
Alzheimer disease (AD) is a disastrous neurodegenerative disease for which presently no
consensus exists neither for the etiology nor for the efficacity of treatments. The amyloid …

[PDF][PDF] A Review of Covid-19 Autoimmune and Neurologic Complications

M Fatahi, F Refahi, E Derakhshan - Journal of Health and Medical Sciences, 2024 - osf.io
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has significantly impacted the
immune system. COVID-19 is considered to be linked to various autoimmune disorders …

Reviews on Long COVID: A scope of the literature.: Update April 2024

CL Khouja, GA Raine, M Harden, K Sutcliffe… - 2024 - eprints.whiterose.ac.uk
• For this update, we identified 36 published reviews and 63 review protocols for Long
COVID.• The number of reviews (n= 36) is fewer than in January 2024 (n= 42), and October …

[PDF][PDF] Trastornos neuropsiquiátricos asociados al Covid persistente

M Díaz, G Moreira, F Núñez, F Ahumada, E Durán… - redclinica.cl
Persistent COVID (PC) is the term used to describe a multisystemic and multifactorial entity,
which follows acute SARS-CoV-2 infection. Symptoms must persist for three months or more …

[HTML][HTML] 154| Long COVID–A Conversation With Dr. Lucette Cysique

M Story - navneuro.com
This episode is a conversation with Dr. Lucette Cysique about long COVID. We discuss
terminology, symptom profiles, epidemiology, biological mechanisms, psychological and …